FDA Approves Pfizer’s Pneumococcal Conjugate Vaccine, Prevnar 20, for Infants and Children
Containing 20 serotypes, Pfizer's Prevnar 20 grants the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine.
Measles Outbreak in American Samoa Causes School Closures
An outbreak of the highly infectious measles virus has led American Samoa to declare a public health emergency.
ACP Begins its Annual Internal Medicine Physician Conference
This gathering is the nation’s largest for internal medicine doctors and has many infectious disease-related scientific sessions.
The ART of Implementing an Antiretroviral Stewardship Program
By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.
SER-109 Is Now FDA-Approved to Treat Recurrent C difficile Infection
Vowst (SER-109) has received FDA approval to treat recurrent C diff infection, making it the first oral microbiome therapeutic.
Specific Enzymes Found to Restrict the Growth of C difficile
The findings of this study could pave the way for new, disease-targeted probiotics.
Sorry Ganciclovir, You’re Just Not the One for Me
Important clinical considerations to know about resistant CMV infections.
World Immunization Week: The Latest Infectious Disease Vaccine Updates
The last week in April is World Immunization Week, and we're recapping the most recent and significant developments in infectious disease vaccines.
COVID-19 Infection Makes Dementia Worse
The study authors wanted to further understand post-COVID-19 infection “brain fog” and sought a new name for the phenomenon.
FDA Fast Tracks Bemnifosbuvir for COVID-19
The antiviral is being studied for treatment for those at high-risk for severe COVID-19, no matter their vaccine status.
COVID-19 Convalescent Plasma: What Is Its Role in Therapy?
The key is using the right dose on the right patient at the right time.
Why Are Children’s COVID-19 Vaccination Rates so Low?
This study surveyed parents’ opinions on the risks of COVID-19 infection versus vaccination to determine how they affected the decision to vaccinate a child against COVID-19.
Fluvoxamine and Inhaled Budesonide: Repurposed and Combined for COVID-19
The combination appears more likely than either agent alone to reduce risk of early COVID-19 symptoms worsening and requiring hospitalization.
Uptick in rCDI Coincided with COVID-19, According to New Analysis
Data from New Haven County, Connecticut, suggests the pandemic might have hurt efforts to curb recurrent CDI.
CREating New Strategies for the Treatment of Resistant Gram-Negative Infections
This was the first study to compare clinical outcomes in carbapenemase-producing (CP-CRE) and non–carbapenemase-producing (nCP-CRE) infections.
Earth Day 2023: Climate Change and Infectious Disease
The floods, heat waves, droughts, and other calamities caused by excessive greenhouse gas emissions also make us more vulnerable to ill effects of pathogens such as bacteria, viruses, plants and fungi.
How Omicron Reinfection and Disease Severity Compare to Previous COVID-19 Variants
Omicron lineages, and especially BA.5, were determined to have higher reinfection rates and lower disease severity than previously circulating variants of concern.
C Diff Advocacy Organization Prepares for its Summit
The Peggy Lillis Foundation will host its summit on Monday and has a number of speakers who will discuss topics related to this healthcare-associated infection (HAI).
Back Again: Vaccines for RSV Near Approval
Two RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. FDA decisions on potential approvals for both could be forthcoming in the next few weeks.
CDI Remains a Major, ‘Multifactorial’ Challenge
While efforts to curb in-hospital infection seem to have paid off, community-acquired cases appear headed in the opposite direction.
A Candid Look Into Uncomplicated Candida Bloodstream Infection Treatment Durations
CDC Updates and Simplifies COVID-19 Vaccine Recommendations
The CDC and FDA now recommend the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines be used for all vaccinations in the US.
340B Drug Pricing Program: What Is It and Why Is It Important?
The 340B program has had a great impact on access to HIV treatment and prevention services in the US.
The Risk of Developing New Diseases After COVID-19: Early Versus Late in the Pandemic
Patients who contracted COVID-19 later in the pandemic (2021-2022) were more likely to develop new chronic diseases after infection than patients who caught COVID-19 in 2020.
Generating Optimism About the Linkage to Care for Viral Hepatitis
A key stakeholder offers his insights on the importance of the new Biden plan to eliminate hepatitis C as well as the federal strategy to get more people linkage to care for hepatitis B.
Anemia Significantly Correlated With COVID-19 Mortality
Anemia is both common and independently associated with poor clinical outcomes in respiratory infections, including COVID-19.
Advances May Pave the Way for an HCV Vaccine
Increased understanding of HCV protective immunity and HCV envelope glycoprotein structure and function may propel development of an HCV vaccine.
Major FDA COVID-19 Vaccine Updates: Only Bivalent Vaccines Now Available
The FDA moved to harmonize primary and booster COVID-19 vaccine doses, deciding only the Moderna and Pfizer-BioNTech bivalent mRNA vaccines should be administered to individuals 6 months and older.
FDA Committee Votes in Support of Approving Sulbactam-Durlobactam
The FDA’s Antimicrobial Drugs Advisory Committee (AMDAC) voted 12-0 in favor of recommending this antibiotic and sets up a PDUFA target action date of May 29.
Invasive Group A Strep infections See Resurgence in England
Since the lifting of public health restrictions, the country saw a sizable increase in incidence rates.
